Experience

Bayview Biosciences LLC

• United States
• Biotechnology Research
• 1 - 100 Employee

• Managing Director

  • Jan 2007 - Present

  Palo Alto, California, United States Advisory, Board of Directors, new company creation and investment portfolio in the pharmaceutical, medical technology and digital therapeutic fields.



Cavalon Therapeutics, Inc.

• United States
• Biotechnology Research

• Co-Founder

  • Feb 2020 - Present

  Palo Alto, California, United States Cavalon develops medicines for neurodegenerative diseases. Our first therapeutic program focuses on breakthrough medicines for Parkinson’s disease. Cavalon is supported by grant funding from the Michael J. Fox Foundation for Parkinson's Research and Cure Parkinson's Trust.



Baymatob

• Australia
• Medical Equipment Manufacturing
• 1 - 100 Employee

• Member Board Of Directors

  • Aug 2021 - Present

  Sydney, New South Wales, Australia Baymatob develops innovative medical devices and predictive algorithms to monitor pregnancy and labor progression. The company’s first platform application is the prediction and management of postpartum hemorrhage (PPH). Baymatob was granted Breakthrough Device Designation by the U.S. Food and Drug Administration in 2021.



The Health Trust

• United States
• Non-profit Organization Management
• 100 - 200 Employee

• Member Board Of Trustees

  • Sep 2021 - Present

  San Jose, California, United States Member of Audit Committee and Finance & Investment Committee. The Health Trust is a $100 million nonprofit operating foundation focused on building health equity in Silicon Valley. Founded in 1996, The Health Trust serves as a funder, a direct service provider and a policy advocate. Programs include Meals on Wheels, additional food and nutrition services, community health promotion, HIV/AIDS case management services and housing services.



Vium

• United States
• Biotechnology Research
• 1 - 100 Employee

• Member Board Of Directors

  • Jan 2017 - Jul 2020

  San Mateo, California, United States Vium was acquired by Recursion Pharmaceuticals. Vium pioneered the digital vivarium for preclinical research, biomarker discovery and translational medicine. Vium’s platform incorporated computer vision, machine learning and advanced sensor technologies to non-invasively observe animals undergoing the early stages of drug testing.



Proteus Digital Health, Inc

• United States
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Chief Platform Officer

  • 2016 - Jan 2020

  Redwood City, CA Proteus Digital Health, Inc was acquired by Otsuka Pharmaceutical. Proteus was a digital medicine company connecting drug taking behavior to therapeutic outcomes. Led the company’s Platform Group. This organization included individuals dedicated to new technology development, ingestible and wearable sensor engineering, digital medicine formulation and development, algorithms and data analytics, manufacturing operations, and corporate development and strategy. Led, negotiated and managed… Show more Proteus Digital Health, Inc was acquired by Otsuka Pharmaceutical. Proteus was a digital medicine company connecting drug taking behavior to therapeutic outcomes. Led the company’s Platform Group. This organization included individuals dedicated to new technology development, ingestible and wearable sensor engineering, digital medicine formulation and development, algorithms and data analytics, manufacturing operations, and corporate development and strategy. Led, negotiated and managed strategic partnerships, equity investments and commercial partnerships with diverse organizations such as TennCare Medicaid, Optum Specialty Pharmacy, Otsuka, Novartis, Oracle, Pepsico, Medtronic, St. Jude Medical, Avery Dennison and ON Semiconductor.

• Chief Product Officer

  • 2010 - 2016

  Redwood City, CA Led the company's Product Group. This organization included individuals dedicated to firmware engineering, mobile and cloud software engineering, user experience and human-centered design, systems integration, data sciences, product management, and corporate development and strategy.

• Senior Vice President, Corporate Development

  • 2007 - 2010

  Redwood City, CA Led the company's Corporate Development and Strategy Group. This organization included the teams in which Proteus developed a digital health product roadmap and negotiated and executed a portfolio of strategic partnerships with organizations like TennCare Medicaid, Optum Specialty Pharmacy, Otsuka, Novartis, Oracle, Pepsico, Medtronic, St. Jude Medical, Avery Dennison and ON Semiconductor.



Catalyst Biosciences

• United States
• Biotechnology Research
• 1 - 100 Employee

• President

  • 2005 - 2007

  Catalyst Biosciences, Inc., (NASDAQ: CBIO) is a clinical-stage biopharmaceutical company developing medicines based on engineered and improved proteases. Its product pipeline includes a Factor VIIa variant and a Factor IX drug for the treatment of hemophilia, and an anti-C3 protease for the treatment of dry age-related macular degeneration. Catalyst has strategic partnerships with Pfizer and ISU Abxis.



Iconix Biosciences

• Biotechnology
• 1 - 100 Employee

• Chief Business Officer

  • 1998 - 2004

  Iconix Biosciences, Inc was acquired by Entelos, Inc. Iconix was a molecular diagnostics and biomarker company that specialized in predictive toxicogenomics products and services. Iconix also pioneered the integration of chemistry, genomics and semiconductor-based technology to enable the pharmaceutical, chemical, agricultural, electronic and food industries to develop safer products. The company's products included DrugMatrix, an informatics offering based on proprietary toxicogenomic data… Show more Iconix Biosciences, Inc was acquired by Entelos, Inc. Iconix was a molecular diagnostics and biomarker company that specialized in predictive toxicogenomics products and services. Iconix also pioneered the integration of chemistry, genomics and semiconductor-based technology to enable the pharmaceutical, chemical, agricultural, electronic and food industries to develop safer products. The company's products included DrugMatrix, an informatics offering based on proprietary toxicogenomic data, analytical tools and data mining algorithms. Iconix also commercialized Drug Signatures, a set of predictive biomarkers for drug development. The company had strategic partnerships with a large number of technology and pharmaceutical companies, including Motorola, Affymetrix, GE Healthcare, Bristol Myers Squibb, Abbott, Eli Lilly and Incyte Genomics. Show less



ARIAD Pharmaceuticals, Inc.

• United States
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Director, Corporate Development

  • 1995 - 1998

  ARIAD Pharmaceuticals, Inc. was acquired by Takeda Pharmaceuticals. Now a subsidiary of Takeda, ARIAD is an oncology company with a technology platform based on signal transduction, combinatorial chemistry and structure-based drug design.



L.E.K. Consulting

• United States
• Business Consulting and Services
• 700 & Above Employee

• Associate Consultant

  • 1990 - 1993

  L.E.K. is a global strategy consulting firm with offices across Europe, the Americas and Asia-Pacific. I focused on client engagements in biotechnology, health care services and telecommunications with long-term assignments in the United States, Australia, Philippines and the United Kingdom.